prompt1 : extract information from  breast pathology report. List the histological classification, i.e. type of cancer or DCIS, subtype, description of any necrosis, any mention of tumor infiltrating lymphocytes,  histological grade, nuclear grade,  lymphovascular invasion, calcification, receptor status, IHC and any other ancillary testing results.  List out and expand the main points.
prompt2 : The report is - Subtype LumA, SPECIMENS: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. D. WIDE EXCISION LEFT BREAST MASS. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. F. SKIN AT ANTERIOR MARGIN. SPECIMEN(S): A. SENTINEL LYMPH NODE #1, LEFT AXILLA. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. D. WIDE EXCISION LEFT BREAST MASS. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. F. SKIN AT ANTERIOR MARGIN. INTRAOPERATIVE CONSULTATION DIAGNOSIS: TPA, Sentinel lymph node #1, left axilla, excision: Negative for carcinoma. TPB, Sentinel lymph node #2, left axilla, excision: Negative for carcinoma. Part D, Left breast, excisional biopsy, gross examination: Tumor approximately 0.3-cm from the posterior margin. Diagnoses called at. f and B) and. (D) by Dr. GROSS DESCRIPTION: A. SENTINEL LYMPH NODE #1, LEFT AXILLA. Received fresh labeled with the patient's identification and designated "sentinel lymph node number one left axilla". is. a fragment of red-tan possible lymphoid tissue measuring 1 x 0.5 x 0.3-cm. Touch preparation is performed. The. entire specimen is submitted, A1. B. SENTINEL LYMPH NODE #2, LEFT AXILLA. Received fresh labeled with the patient identification and designated "sentinel lymph node number two left axilla" is. fragment of red-tan possible lymphoid tissue measuring 1.3 x 0.5 x 0.2 cm. Touch preparation is performed. The. entire specimen is submitted, B1. C. NON-SENTINEL LYMPH NODE LEFT AXILLA. Received in formalin labeled with the patient's identification and designated "Non-sentinel lymph node left axilla" is a. fragment of adipose tissue, 2.5 x 2.4 x 0.5 cm, consisting of one possible lymph node measuring 1 x 0.5 x 0.4 cm. The lymph node is submitted, C1. D. WIDE EXCISION LEFT BREAST MASS. Received fresh labeled with the patient's identification and designated "wide excision left breast" is a previously. inked, oriented, 89-g, 9 x 8.4 x 2.5 cm lumpectomy specimen. The single clip designates superior, double-lateral,. triple-anterior. ink code: Anterior-yellow, posterior-black, superior-blue, inferior-orange, medial- green, lateral-red. The specimen is serially sectioned from medial to lateral into 7 slices revealing an irregular friable soft tan mass, 3 x. 2.4 x 0.9 cm, located 0.3-cm from the nearest posterior margin (Slices 3-5). A previous hemorrhagic biopsy cavity is. identified 0.6-cm from the mass (lateral), measuring 1.4 x 0.8 x 0.7 cm. A portion of the specimen is submitted for. tissue procurement. Representatively submitted: D1-D2: Representative perpendicular sections, medial margin. D3: Slice 2, posterior. D4: Slice 2, superior. D5-D11: Slice 3, entirely submitted, D8 and D10 demonstrating tumor. D12-D15: Slice 4, posterior/superior/anterior/superior, tumor. D16-D19: Slice 5, D16-D18 demonstrating biopsy cavity. D20-D21: Slice 6, superior, remainder of biopsy cavity. D22-D25: Perpendicular sections lateral margin, entirely submitted. E. ADDITIONAL NEW MARGIN SUPERIOR LATERAL. Received in formalin labeled with the patient's identification and designated "additional new margin superior lateral". is a previously inked, 6-g, 5.2 x 3 x 0.8 cm fragment of fibroadipose tissue. Ink code: Superior-blue, lateral-red. Sectioning shows no obvious gross abnormalities. The entire specimen is submitted, E1-E2 (superior), E3-E4. (lateral). F. SKIN AT ANTERIOR MARGIN. Received in formalin labeled with the patient's identification and designated "skin at anterior margin" is a slender. fragment of unoriented light beige skin measuring 2.1 x 0.6 x 0.2 cm. the entire specimen is submitted, F1. DIAGNOSIS: A. LYMPH NODE, SENTINEL #1, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). B. LYMPH NODE, SENTINEL #2, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). C. LYMPH NODE, non-SENTINEL, left AXILLA, EXCISION: - ONE LYMPH NODE, NEGATIVE FOR METASTASES (0/1). D. BREAST, LEFT, WIDE LOCAL EXCISION: INVASIVE DUCTAL CARCINOMA, SBR GRADE 2, MEASURING 1.8-CM. - INTERMEDIATE NUCLEAR GRADE, DUCTAL CARCINOMA IN SITU, SOLID AND CRIBRIFORM TYPE WITH. CENTRAL NECROSIS AND MICROCALCIFICATIONS WITH A COMPONENT OF INTRACYSTIC PAPILLARY. CARCINOMA. - SURGICAL RESECTION MARGINS NEGATIVE FOR INVASIVE TUMOR. - MICROSCOPIC FOCUS OF LOW GRADE DUCTAL CARCINOMA IN SITU AT INFERIOR SURGICAL. RESECTION MARGIN. - BIOPSY SITE CHANGES WITH FIBROSIS AND GRANULATION TISSUE. - SEE SYNOPTIC REPORT AND SEE NOTE. e. breast, left, additional superior lateral margin, excision: - fibroadipose tissue, NO TUMOR SEEN. f. skin, anterior margin, excision: - SKIN tissue, NO TUMOR SEEN. NOTE: Ductal carcinoma is identified in 5 consecutive slices. The tumor is composed of 3 components, invasive, in. situ and intracystic. The gross measurement of the tumor is a 3-cm. The largest confluent invasive tumor measures. 1.8-cm. A microscopic focus of low-grade DCIS is identified at the inferior surgical resection margin. SYNOPTIC REPORT - BREAST. Specimen Type: Excision. Needle Localization: Laterality: Left. Invasive Tumor: Present. Multifocality: No. WHO CLASSIFICATION. Invasive ductal carcinoma, NOS 8500/3. Tumor size: 1.8cm. Tumor Site: Not specified. Margins: Negative. Distance from closest margin: 0.3cm. deep. Tubular Score: 2. Nuclear Grade: 2. Mitotic Score: 2. Modified Scarff Bloom Richardson Grade: 2. Necrosis: Absent. Vascular/Lymphatic Invasion: None identified. Lobular neoplasia: None. Lymph nodes: Sentinel lymph node only. Lymph node status: Negative 0/3. DCIS present. Margins involved by DCIS: inferior. DCIS Quantity: Estimate 20%. DCIS Type: Solid. Cribriform. intracystic. DCIS Location:Associated with invasive tumor. Nuclear grade: Intermediate. Necrosis: Present. Location of CA++: DCIS. ER/PR/HER2 Results. ER: Positive. PR: Positive. HER2: Negative by IHC. Performed on Case: Pathological staging (pTN): pT 1c N 0. CLINICAL HISTORY: None given. PRE-OPERATIVE DIAGNOSIS: Left breast mass. ADDENDUM: ONCOTYPE DX BREAST CANCER ASSAY. RESULTS: Recurrence Score: 0. CLINICAL EXPERIENCE: Patients with a recurrence score of: 0 in the clinical validation study had an average. rate of Distant Recurrence at 10 years of 3%. ER Score: 11.8 Positive. PR Score: 10 Positive. Her2 Score: 9.8 Negative. Interpretation: ER Negative < 6.5 Positive >= 6.5. PR. Negative < 5.5 Positive >= 5.5. Her2 Negative <10.7 Positive >=11.5 Equivocal = 10.7 - 11.4. See separate. 1 report for further information. Microscopic/Diagnostic Dictation: Final Review: Pathologist,. Final: Pathologist,. Addendum: Pathologist,. Addendum Final: Pathologist,.

expanded version (tokens=2363) : 
 The breast pathology report describes a Luminal A subtype of breast cancer. The report identifies several specimens including Sentinel lymph node #1 and #2, Non-sentinel lymph node left axilla, wide excision of the left breast mass, additional new margin superior lateral, and skin at anterior margin. 

The histological classification is invasive ductal carcinoma, SBR grade 2, measuring 1.8 cm, with an intermediate nuclear grade. The ductal carcinoma in situ (DCIS) is solid and cribiform with central necrosis and microcalcifications, and a component of intracystic papillary carcinoma.

The histological grade is intermediate with a tubular score of 2, mitotic score of 2, and a modified Scarff Bloom Richardson grade of 2. Necrosis is present in the DCIS component.

Tumor infiltrating lymphocytes and lymphovascular invasion are not mentioned in the report.

Margins are negative for invasive tumor, except for a microscopic focus of low grade DCIS present at the inferior surgical resection margin. The biopsy site shows changes with fibrosis and granulation tissue.

Receptor status for estrogen and progesterone is positive, while HER2 receptor status is negative based on IHC. Oncotype DX breast cancer assay results show a recurrence score of 0. 

The reports contain several other ancillary testing results, including distance from closest margin (0.3 cm deep), DCIS type (solid, cribriform,

prompt : Please generate a succinct report in 75 words from the above information. Exclude any filler words or sentences. If something is not mentioned or specified, exclude it from the report. Low verbosity.

final output (tokens=2513) : 
 The report describes Luminal A subtype breast cancer with invasive ductal carcinoma and solid and cribriform DCIS with central necrosis. The tumor is 1.8 cm in size, intermediate grade, positive for estrogen and progesterone receptors, negative for HER2 receptor, and has a recurrence score of 0. Margins are negative for invasive tumor except for a microscopic focus of low-grade DCIS at the inferior surgical resection margin. No tumor infiltrating lymphocytes or lymphovascular invasion noted.

